Last updated: April 3, 2024
Sponsor: Cardiovascular Research Foundation, New York
Overall Status: Completed
Phase
N/A
Condition
Circulation Disorders
Occlusions
Cardiovascular Disease
Treatment
N/AClinical Study ID
NCT05949515
RESCU
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Data from all patients who received SSO2 treatment and have completed a minimum of 3months follow up will be collected at each participating center; there are no otherexclusion criteria aside from date of treatment.
Exclusion
Exclusion Criteria:
Study Design
Total Participants: 403
Study Start date:
July 31, 2023
Estimated Completion Date:
March 31, 2024
Study Description
Connect with a study center
Baptist Hospital of Miami, Inc and Its Miami Cardiac and Vascular Institute
Miami, Florida 33176
United StatesSite Not Available
NCH Healthcare System
Naples, Florida 34102
United StatesSite Not Available
Oakwood Healthcare, Inc
Dearborn, Michigan 48124
United StatesSite Not Available
Minneapolis Heart Institute Foundation
Minneapolis, Minnesota 55407
United StatesSite Not Available
Northwell Health, Inc
Great Neck, New York 11021
United StatesSite Not Available
OhioHealth Research Institute
Columbus, Ohio 43214
United StatesSite Not Available
Avita Health
Galion, Ohio 44833
United StatesSite Not Available
St. Mary's Medical Center
Huntington, West Virginia 25702
United StatesSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.